CellSource Co

CellSource Co Assets per Share

The Total Assets per Share of CellSource Co (4880.T) as of Oct 27, 2026 is 358.69 JPY. In the previous year, Total Assets per Share was 361.50 JPY — a change of -0.78% (lower).

Assets per Share

358.69JPY

YoY

-0.78%

Last updated:

Total Assets per Share of CellSource Co is 2025 358.69 JPY. Total Assets per Share of CellSource Co was 2024 361.50 JPY. It decreases by -0.78% lower compared to the previous year.

The CellSource Co Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
35.15 JPY
Jan 1, 2019
93.37 JPY
Jan 1, 2020
118.62 JPY
Jan 1, 2021
169.74 JPY
Jan 1, 2022
232.03 JPY
Jan 1, 2023
347.53 JPY
Jan 1, 2024
361.50 JPY
Jan 1, 2025
358.69 JPY
The CellSource Co Assets per Share history
YEARAssets per ShareYoY
358.69JPY-0.78%
361.50JPY+4.02%
347.53JPY+49.77%
232.03JPY+36.70%
169.74JPY+43.10%
118.62JPY+27.04%
93.37JPY+165.63%
35.15JPY+112.88%
16.51JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Total Assets per Share of CellSource Co is 358.69 JPY in 2025.

Total Assets per Share of CellSource Co changed from 361.50 JPY to 358.69 JPY, representing a -0.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share CellSource Co since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — CellSource Co

All Key Metrics — CellSource Co